You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dose adjusted

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Recruiting
  • Diffuse Large Cell Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Richter Syndrome Trial in United States (Venetoclax, DA-EPOCH-R, R-CHOP)

Recruiting
  • Richter Syndrome
  • Boston, Massachusetts
  • +2 more
Jan 6, 2023

DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Active, not recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,

Suspended
  • Burkitt Lymphoma
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)

Completed
Has Results
  • Hodgkin Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Campath
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022

T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

Not yet recruiting
  • T Cell Lymphoma
  • New Haven, Connecticut
    Yale Smilow Cancer Hospital
Aug 14, 2023

Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • DE-HyART
  • +3 more
  • Delhi, India
    Rajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023

Complications; Cesarean Section, Hypotension Trial in London (Phenylephrine)

Completed
  • Complications; Cesarean Section
  • Hypotension
  • London, Ontario, Canada
    Victoria Hospital
Sep 23, 2022

Regional Anesthesia Morbidity, Cesarean Section Complications, Local Anesthetic Complication Trial (standardized dose, adjusted

Not yet recruiting
  • Regional Anesthesia Morbidity
  • +2 more
  • standardized dose
  • adjusted dose
  • (no location specified)
Jan 31, 2022

Appendicitis Acute Trial (Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT)

Not yet recruiting
  • Appendicitis Acute
  • Weight-adjusted low-dose contrast media paired with low-radiation dose abdomen CT
  • (no location specified)
May 18, 2023

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
Has Results
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)

Completed
Has Results
  • Lymphoma, T-Cell
  • Lymphoma, Extranodal NK-T-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022

Lean Body Weight-adjusted Rocuronium Dose and Intubation

Not yet recruiting
  • Body Weight Changes
  • +2 more
  • he patients who are administered rocuronium according to LBW were categorized as "LBW", and The group number for those administer according to TBW was categorized as "K".
  • (no location specified)
Jul 26, 2022

Community-acquired Pneumonia, Sepsis, Inflammatory Response Trial in Greece (Tablets, Clarithromycin 500mg)

Active, not recruiting
  • Community-acquired Pneumonia
  • +5 more
  • Alexandroupolis, Greece
  • +25 more
Jan 11, 2023

Lymphoma, Mantle Cell, Mantle Cell Lymphoma Trial run by the NCI (Rituximab (R), EPOCH, Bortezomib (B))

Active, not recruiting
Has Results
  • Lymphoma, Mantle Cell
  • Mantle Cell Lymphoma
  • Rituximab (R)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 21, 2021

Pregnancy, HIV-1-infection Trial (Standard dose Truvada®, Pregnancy-adjusted dose Truvada®)

Withdrawn
  • Pregnancy
  • HIV-1-infection
  • Standard dose Truvada®
  • Pregnancy-adjusted dose Truvada®
  • (no location specified)
Mar 28, 2022

Venous Thromboembolism Trial in Canada, United States (Enoxaparin)

Recruiting
  • Venous Thromboembolism
  • Philadelphia, Pennsylvania
  • +3 more
Oct 14, 2021

Psoriasis Vulgaris Trial in Valencia (Brodalumab)

Recruiting
  • Psoriasis Vulgaris
  • Brodalumab
  • Brussels, Belgium
  • +21 more
Dec 12, 2022

Low Fat Meal - Unadjusted Insulin Dose, High Fat Meal - Unadjusted Insulin Dose, High Fat Meal - Adjusted Insulin Dose +30

Completed
  • Low Fat Meal - Unadjusted Insulin Dose
  • +3 more
  • Meal composition
  • Rapid-Acting Insulin Dose
  • (no location specified)
Mar 2, 2021

Warfarin Dose Prescription in Admixed Caribbean Hispanics

Completed
  • Atrial Fibrillation
  • +4 more
  • Genotype-guided
  • Standard-of-Care
  • Miami, Florida
  • +2 more
May 17, 2022

COVID, Thrombosis, Pulmonary Embolism Trial in France (Enoxaparin)

Completed
  • COVID
  • +3 more
  • Amiens, France
  • +16 more
Dec 17, 2021

Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive, Plasmablastic Lymphoma Trial in United States (EPOCH-R,

Active, not recruiting
Has Results
  • Burkitt Lymphoma
  • +2 more
  • La Jolla, California
  • +29 more
Nov 2, 2021

Atrial Fibrillation Trial in Rochester (Apixaban, Warfarin)

Terminated
Has Results
  • Atrial Fibrillation
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 23, 2021

Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +8 more
  • Polatuzumab Vedotin
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Cholera, Vibrio Cholerae Infection Trial in Lusaka (Oral Cholera Vaccine, Adjusted Dose Oral Cholera Vaccine)

Completed
  • Cholera
  • Vibrio Cholerae Infection
  • Oral Cholera Vaccine
  • Adjusted Dose Oral Cholera Vaccine
  • Lusaka, Zambia
    Center for Infectious Disease Research - Zambia
Apr 1, 2021